Form D Explorer

Form D — Sentonix, Inc.

0002039609-25-000001 · filed 2025-05-12

Offering

Industry
Pharmaceuticals
Exemptions
06b
Total offering
$10,500,000
Total sold
$6,499,590
Minimum investment
$10,000
Investors
Sales commission
Finders' fees

Issuer

Name
Sentonix, Inc.
CIK
2039609
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2023
Address
1167 MASSACHUSETTS AVE
ARLINGTON, MA 02476
Phone
617-388-6440

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View original on SEC EDGAR.